Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$147M |
| 2 |
NVIDIA
NVDA
|
+$129M |
| 3 |
iShares Bitcoin Trust
IBIT
|
+$124M |
| 4 |
SPR
Spirit AeroSystems
SPR
|
+$109M |
| 5 |
INFN
Infinera Corporation Common Stock
INFN
|
+$98.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$97.9M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$93.9M |
| 3 |
UnitedHealth
UNH
|
+$68.8M |
| 4 |
Salesforce
CRM
|
+$57M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$56.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.46% |
| 2 | Financials | 3.89% |
| 3 | Industrials | 3.8% |
| 4 | Consumer Discretionary | 3.36% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
1176
PUT
Novo Nordisk
NVO
$207B
| $2.08M | 0.01% |
17,500
+10,400
| +146% | +$1.39M |
|
1177
Orthofix Medical
OFIX
$399M
| $2.08M | 0.01% |
133,260
+1,994
| +2% | +$31.9K |
|
1178
Flowserve
FLS
$10.2B
| $2.07M | 0.01% |
+40,142
| New | +$1.93M |
|
1179
CALL
Mastercard
MA
$525B
| $2.07M | 0.01% |
4,200
+1,100
| +35% | +$512K |
|
1180
TriCo Bancshares
TCBK
$1.74B
| $2.07M | 0.01% |
48,503
+40,966
| +544% | +$1.77M |
|
1181
Guidewire Software
GWRE
$16B
| $2.07M | 0.01% |
11,299
-4,903
| -30% | -$745K |
|
1182
Air Products & Chemicals
APD
$68.2B
| $2.06M | 0.01% |
+6,929
| New | +$1.89M |
|
|
PGRE
1183
DELISTED
Paramount Group
PGRE
| $2.06M | 0.01% |
417,886
-1,122
| -0.3% | -$5.56K |
|
1184
Rapid7
RPD
$822M
| $2.06M | 0.01% |
51,535
+38,518
| +296% | +$1.45M |
|
1185
Iovance Biotherapeutics
IOVA
$3.65B
| $2.06M | 0.01% |
218,927
-80,958
| -27% | -$767K |
|
1186
PUT
Constellation Energy
CEG
$96.9B
| $2.05M | 0.01% |
7,900
-81,900
| -91% | -$16.3M |
|
1187
CubeSmart
CUBE
$9.21B
| $2.04M | 0.01% |
37,943
-134,005
| -78% | -$6.65M |
|
1188
PUT
Devon Energy
DVN
$53.1B
| $2.04M | 0.01% |
52,200
-5,300
| -9% | -$233K |
|
1189
PUT
Crocs
CROX
$6.03B
| $2.04M | 0.01% |
14,100
-2,200
| -13% | -$300K |
|
1190
iShares Core US Aggregate Bond ETF
AGG
$138B
| $2.04M | 0.01% |
+20,159
| New | +$2.01M |
|
1191
BJ's Restaurants
BJRI
$1.43B
| $2.03M | 0.01% |
62,498
-13,719
| -18% | -$442K |
|
1192
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $2.03M | 0.01% |
32,626
-8,708
| -21% | -$525K |
|
1193
PUT
Lowe's Companies
LOW
$122B
| $2.03M | 0.01% |
7,500
+1,600
| +27% | +$387K |
|
1194
IPG Photonics
IPGP
$3.01B
| $2.02M | 0.01% |
+27,224
| New | +$2.04M |
|
1195
CALL
Fluor
FLR
$6.86B
| $2.02M | 0.01% |
+42,300
| New | +$1.99M |
|
1196
McGrath RentCorp
MGRC
$2.85B
| $2.01M | 0.01% |
19,139
-132,205
| -87% | -$14M |
|
1197
RPM International
RPM
$13.6B
| $2.01M | 0.01% |
+16,642
| New | +$1.93M |
|
1198
CALL
West Pharmaceutical
WST
$24.9B
| $2.01M | 0.01% |
+6,700
| New | +$2.05M |
|
1199
Herbalife
HLF
$1.32B
| $2M | 0.01% |
277,735
+24,602
| +10% | +$227K |
|
1200
Tennant Co
TNC
$1.16B
| $2M | 0.01% |
20,785
-22,950
| -52% | -$2.24M |
|
Similar funds
Paul Tudor Jones's Q3 2024 Portfolio in Review
As of Q3 2024, Paul Tudor Jones held 3,231 positions worth $27.5B, up 41% from $19.5B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Paul Tudor Jones deployed $6.72B of net new capital in Q3 2024, opening 973 new positions and adding to 833 existing holdings. Its largest new stake was iShares Russell 2000 ETF: 686,581 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 6.5% of assets, down from 8.7% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Apple, an estimated $97.9M trimmed.
- Paul Tudor Jones's largest Q3 2024 buy was iShares Russell 2000 ETF: 686,581 shares worth $152M.
- Paul Tudor Jones added most to NVIDIA in Q3 2024, an estimated $129M increase.
- Paul Tudor Jones's biggest Q3 2024 reduction was Apple, cutting an estimated $97.9M.
- Paul Tudor Jones fully exited Bristol-Myers Squibb in Q3 2024, selling an estimated $93.9M.
- Paul Tudor Jones's ten largest holdings make up 47% of its $27.5B portfolio in Q3 2024.
- Paul Tudor Jones opened 973 new positions and closed 594 in Q3 2024.
- Paul Tudor Jones's portfolio value rose 41% quarter-over-quarter to $27.5B.
Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.